C4 Therapeutics (CCCC) Other Non Operating Income (2019 - 2023)

C4 Therapeutics' Other Non Operating Income history runs 3 years deep, the most recent figure standing at -$621000.0 for Q3 2023.

• In Q3 2023, Other Non Operating Income changed N/A year-over-year to -$621000.0; the TTM figure through Dec 2024 stood at -$621000.0 (changed 0.0% YoY), while the FY2023 annual figure was -$621000.0, changed N/A from the prior year.
• Other Non Operating Income was -$621000.0 for Q3 2023 at C4 Therapeutics, down from $43000.0 in the prior quarter.
• In the past five years, Other Non Operating Income ranged from a high of $43000.0 in Q3 2020 to a low of -$621000.0 in Q3 2023.
• Historically, Other Non Operating Income has averaged -$193000.0 across 3 years, with a median of -$1000.0 in 2019.
• Biggest YoY gain for Other Non Operating Income was 4400.0% in 2020; the steepest drop was 4400.0% in 2020.
• A 3-year view of Other Non Operating Income shows it stood at -$1000.0 in 2019, then surged by 4400.0% to $43000.0 in 2020, then tumbled by 1544.19% to -$621000.0 in 2023.
• The last three Other Non Operating Income figures came in at -$621000.0 (Q3 2023), $43000.0 (Q3 2020), and -$1000.0 (Q3 2019), per Business Quant data.